NCT04857814View on ClinicalTrials.gov

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Progressive Fibrosing Interstitial Lung DiseaseLung TransplantCystic FibrosisBronchiectasisPulmonary Tuberculosis
Interventions
DEVICE

ADAMM- RSM Device

All participants will wear the ADAMM- RSM device for a 6 month period

Trial Locations (1)

T6G 2B7

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER